These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 19589055

  • 1. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.
    Geldenhuys WJ, Van der Schyf CJ.
    Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055
    [Abstract] [Full Text] [Related]

  • 2. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
    Johnson CN, Ahmed M, Miller ND.
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):642-54. PubMed ID: 18729016
    [Abstract] [Full Text] [Related]

  • 3. 5-HT6 receptors: a novel target for cognitive enhancement.
    Mitchell ES, Neumaier JF.
    Pharmacol Ther; 2005 Dec; 108(3):320-33. PubMed ID: 16005519
    [Abstract] [Full Text] [Related]

  • 4. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML.
    J Med Chem; 2014 Sep 11; 57(17):7160-81. PubMed ID: 24850589
    [Abstract] [Full Text] [Related]

  • 5. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 Feb 15; 19(4):1115-7. PubMed ID: 19152787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3214-6. PubMed ID: 19433358
    [Abstract] [Full Text] [Related]

  • 11. 5-HT(6) receptor and cognition.
    Codony X, Vela JM, Ramírez MJ.
    Curr Opin Pharmacol; 2011 Feb 15; 11(1):94-100. PubMed ID: 21330210
    [Abstract] [Full Text] [Related]

  • 12. 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment.
    Rossé G, Schaffhauser H.
    Curr Top Med Chem; 2010 Feb 15; 10(2):207-21. PubMed ID: 20166958
    [Abstract] [Full Text] [Related]

  • 13. Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease.
    Geldenhuys WJ, Van der Schyf CJ.
    Curr Top Med Chem; 2008 Feb 15; 8(12):1035-48. PubMed ID: 18691131
    [Abstract] [Full Text] [Related]

  • 14. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
    Esbenshade TA, Fox GB, Cowart MD.
    Mol Interv; 2006 Apr 15; 6(2):77-88, 59. PubMed ID: 16565470
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-HT6 receptor antagonists as treatment for age-related cognitive decline.
    Quiedeville A, Boulouard M, Da Silva Costa-Aze V, Dauphin F, Bouet V, Freret T.
    Rev Neurosci; 2014 Apr 15; 25(3):417-27. PubMed ID: 24622786
    [Abstract] [Full Text] [Related]

  • 17. 1-Sulfonylindazoles as potent and selective 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 May 01; 19(9):2413-5. PubMed ID: 19345582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.